Cancer researchers—including Elizabeth M. Jaffee, MD, FAACR, of the Sidney Kimmel Cancer Center at Johns Hopkins; Robert H. Vonderheide, MD, DPhil, FAACR, of the Abramson Cancer Center of the University of Pennsylvania; Kornelia Polyak, MD, PhD, FAACR, of Dana-Farber Cancer Institute and Harvard Medical School; Cornelia Ulrich, PhD, of the Huntsman Cancer Institute and University of Utah; Electra D. Paskett, PhD, FAACR, of The Ohio State University, and Anna Barker, PhD, FAACR, of the Ellison Medical Institute—explain how certain provisions of the White House Office of Management and Budget’s proposal to change how federal grants are awarded and managed would be harmful to U.S. scientific and medical innovation.
The post Cancer Researchers Explain How OMB’s Proposed Changes to Federal Grantmaking Will Cause Delays, Reduce Transparency, and Undermine Merit-based Processes appeared first on American Association for Cancer Research (AACR).
Source: Oncology
